Epigenetic Modifications Mediated by the AML1/ETO and MLL Leukemia Fusion Proteins

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-642-38404-2_6
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Chromatin modifications induced by the AML1-ETO fusion protein reversibly silence its genomic targets through AML1 and Sp1 binding motifs

  2012cited by this paper
• Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia.

  2012cited by this paper
• The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells.

  2012cited by this paper
• Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding

  2012cited by this paper
• Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia

  2011cited by this paper
• The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation

  2011cited by this paper
• The ability of MLL to bind RUNX1 and methylate H3K4 at PU.1 regulatory regions is impaired by MDS/AML-associated RUNX1/AML1 mutations.

  2011cited by this paper
• BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

  2011cited by this paper
• The HDAC class I-specific inhibitor entinostat (MS-275) effectively relieves epigenetic silencing of the LAT2 gene mediated by AML1/ETO

  2011cited by this paper
• Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale

  2011cited by this paper
• Regulation of the adaptor molecule LAT2, an in vivo target gene of AML1/ETO (RUNX1/RUNX1T1), during myeloid differentiation

  2011cited by this paper
• MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L.

  2011cited by this paper
• Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor.

  2011cited by this paper
• CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis.

  2011cited by this paper
• The Brd4 Extraterminal Domain Confers Transcription Activation Independent of pTEFb by Recruiting Multiple Proteins, Including NSD3

  2011cited by this paper
• Array‐based DNA methylation profiling in acute myeloid leukaemia

  2011cited by this paper
• MicroRNA programs in normal and aberrant stem and progenitor cells.

  2011cited by this paper
• C-KIT mutation cooperates with full-length AML1-ETO to induce acute myeloid leukemia in mice

  2011cited by this paper
• RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

  2011cited by this paper
• DNA Methylation Profiles and Their Relationship with Cytogenetic Status in Adult Acute Myeloid Leukemia

  2010cited by this paper
• The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis.

  2010cited by this paper
• MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele.

  2010cited by this paper
• Suppression of inflammation by a synthetic histone mimic

  2010cited by this paper
• Pro isomerization in MLL1 PHD3-bromo cassette connects H3K4me readout to CyP33 and HDAC-mediated repression.

  2010cited by this paper
• The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression.

  2010cited by this paper
• Phosphorylation of MLL by ATR is Required for Execution of Mammalian S Phase Checkpoint

  2010cited by this paper
• Selective inhibition of BET bromodomains

  2010cited by this paper
• Structure of the MLL CXXC domain–DNA complex and its functional role in MLL-AF9 leukemia

  2010cited by this paper
• Promoter hypermethylation in MLL-r infant acute lymphoblastic leukemia: biology and therapeutic targeting.

  2010cited by this paper
• Binding of the MLL PHD3 finger to histone H3K4me3 is required for MLL-dependent gene transcription.

  2010cited by this paper
• A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription.

  2010cited by this paper
• Multiple interactions recruit MLL1 and MLL1 fusion proteins to the HOXA9 locus in leukemogenesis.

  2010cited by this paper
• AFF4, a component of the ELL/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia.

  2010cited by this paper
• Self-association mediated by the Ras association 1 domain of AF6 activates the oncogenic potential of MLL-AF6.

  2010cited by this paper
• Robust in vivo differentiation of t(8;21)-positive acute myeloid leukemia blasts to neutrophilic granulocytes induced by treatment with dasatinib

  2010cited by this paper
• DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia.

  2010cited by this paper
• Structural basis for the requirement of additional factors for MLL1 SET domain activity and recognition of epigenetic marks.

  2009cited by this paper
• The molecular biology of mixed lineage leukemia

  2009cited by this paper
• HOXA9 is required for survival in human MLL-rearranged acute leukemias.

  2009cited by this paper
• Specific promoter methylation identifies different subgroups of MLL-rearranged infant acute lymphoblastic leukemia, influences clinical outcome, and provides therapeutic options.

  2009cited by this paper
• Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization.

  2009cited by this paper
• A role for MEIS1 in MLL-fusion gene leukemia.

  2009cited by this paper
• Identification of new microRNA genes and aberrant microRNA profiles in childhood acute lymphoblastic leukemia

  2009cited by this paper
• DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication.

  2008cited by this paper
• Distinct microRNA expression profiles in acute myeloid leukemia with common translocations

  2008cited by this paper
• Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia.

  2008cited by this paper
• The human SIN3B corepressor forms a nucleolar complex with leukemia-associated ETO homologues

  2008cited by this paper
• H3K79 methylation profiles define murine and human MLL-AF4 leukemias.

  2008cited by this paper
• Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.

  2008cited by this paper
• Epigenetics in cancer.

  2008cited by this paper
• Complementing mutations in core binding factor leukemias: from mouse models to clinical applications

  2008cited by this paper
• Menin critically links MLL proteins with LEDGF on cancer-associated target genes.

  2008cited by this paper
• Selective anti-leukaemic activity of low-dose histone deacetylase inhibitor ITF2357 on AML1/ETO-positive cells

  2008cited by this paper
• PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis

  2008cited by this paper
• Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the ‘second hit’ hypothesis

  2008cited by this paper
• Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity.

  2008cited by this paper
• Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO

  2008cited by this paper
• MLL protects CpG clusters from methylation within the Hoxa9 gene, maintaining transcript expression

  2008cited by this paper
• Review Articles (434 articles)

  2008cited by this paper
• Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential.

  2007cited by this paper
• A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification.

  2007cited by this paper
• The p21Waf1 pathway is involved in blocking leukemogenesis by the t(8;21) fusion protein AML1-ETO.

  2007cited by this paper
• Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion oncoprotein

  2007cited by this paper
• Reversal of p15/INK4b hypermethylation in AML1/ETO-positive and -negative myeloid leukemia cell lines.

  2007cited by this paper
• MLL translocations, histone modifications and leukaemia stem-cell development

  2007cited by this paper
• Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors.

  2007cited by this paper
• Mll has a critical role in fetal and adult hematopoietic stem cell self-renewal.

  2007cited by this paper
• Targeting AML1/ETO-Histone Deacetylase Repressor Complex: A Novel Mechanism for Valproic Acid-Mediated Gene Expression and Cellular Differentiation in AML1/ETO-Positive Acute Myeloid Leukemia Cells

  2007cited by this paper
• Protein arginine-methyltransferase-dependent oncogenesis

  2007cited by this paper
• Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein.

  2007cited by this paper
• MicroRNAs 17-5p–20a–106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation

  2007cited by this paper
• Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia.

  2007cited by this paper
• A TAF4-homology domain from the corepressor ETO is a docking platform for positive and negative regulators of transcription

  2007cited by this paper
• The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling.

  2007cited by this paper
• Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9

  2006cited by this paper
• Silencing of the tumor suppressor gene FHIT is highly characteristic for MLL gene rearranged infant acute lymphoblastic leukemia

  2006cited by this paper
• Inhibitors of DNA methylation and histone deacetylation independently relieve AML1/ETO‐mediated lysozyme repression

  2006cited by this paper
• Regulation of MLL1 H3K4 methyltransferase activity by its core components

  2006cited by this paper
• The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity.

  2006cited by this paper
• ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETO

  2006cited by this paper
• The MLL recombinome of acute leukemias

  2006cited by this paper
• A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis

  2006cited by this paper
• WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development.

  2005cited by this paper
• Interplay of RUNX1/MTG8 and DNA methyltransferase 1 in acute myeloid leukemia.

  2005cited by this paper
• hDOT1L links histone methylation to leukemogenesis.

  2005cited by this paper
• A microRNA polycistron as a potential human oncogene

  2005cited by this paper
• Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts

  2005cited by this paper
• Global and Hox-specific roles for the MLL1 methyltransferase.

  2005cited by this paper
• The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis.

  2005cited by this paper
• Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF.

  2005cited by this paper
• Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications.

  2005cited by this paper
• Transcriptional Repression of the Neurofibromatosis-1 Tumor Suppressor by the t(8;21) Fusion Protein

  2005cited by this paper
• A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis.

  2005cited by this paper
• Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.

  2005cited by this paper
• Functional contribution of EEN to leukemogenic transformation by MLL-EEN fusion protein

  2004cited by this paper
• Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization

  2004cited by this paper
• E Protein Silencing by the Leukemogenic AML1-ETO Fusion Protein

  2004cited by this paper
• MEIS 1 expression is downregulated through promoter hypermethylation in AML1-ETO acute myeloid leukemias

  2004cited by this paper
• ETO interacting proteins

  2004cited by this paper
• MicroRNA-Directed Cleavage of HOXB8 mRNA

  2004cited by this paper

• Complex Chromosomal Aberrations in Patients with Post-Transplantation Relapses of Acute Leukemias: Clinical and Theoretical Aspects

  2015cites this paper
• Temporal variations in Commercial Fish Community of a Floodplain of the River Ravi, Pakistan

  2014cites this paper